department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Vaxcyte, Inc. ($PCVX) · pharmadog

PUBLIC COMPANY

$PCVXVaxcyte, Inc.

San Carlos, CA, USupdated 1h ago

SEC EDGAR ↗Yahoo Finance ↗

community read0 votes

pipeline

3

marketed

0

phase 3

1

catalysts ytd

1

approvals ytd

0

recalls ytd

0

Pipeline(3)

pipeline depth3 products

1Preclinical1Phase 21Phase 3

Streptococcal Pneumonia

Streptococcal Pneumonia

Preclinical

VAXA-1

Streptococcal Infections

Upcoming

no upcoming catalysts on record

Recent(90d)

earnings (1)

Vaxcyte, Inc. earnings

view all catalysts →

🐶 Hiring Signal

64 open roles at Vaxcyte, Inc. →

Where Vaxcyte, Inc. is staffing up — a leading indicator of pipeline and commercial priorities.

therapeutic areaInfectious Disease & Vaccines 64

departmentIT & Engineering 15 Manufacturing / CMC 14 R&D / Discovery 14 Quality 6 Finance 3 Regulatory 3

News

no news has mentioned this company yet

identifiers

ticker

$PCVX

SEC CIK

0001649094

country

US

source

sec_tickers

top tags

Pulmonology2 Infectious Disease1

mentioned in

0news items

entity-linker matched

Data sources

last refreshed 4m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Active trials

phase3Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Prior Pneumococcal Vaccinationactive not recruitingn=752
phase3A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 With Influenza Vaccine in Adults ≥ 50 Years of Ageactive not recruitingn=1,390
phase1A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young Adultsrecruitingn=80
phase3Safety, Tolerability, and Immunogenicity of VAX-31 in Adults ≥50 Years With Immunobridging to Adults 18-49active not recruitingn=4,049
phase2A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infantsactive not recruitingn=905
phase2Safety, Tolerability, and Immunogenicity of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Healthy Infantscompletedn=802
phase2Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adultscompletedn=1,015
phase2Safety, Tolerability, and Immunogenicity Study of a 24-Valent Pneumococcal Conjugate Vaccine (VAX-24) in Older Adultscompletedn=207

more trials →

$PCVX58.39+4.12%

Insider activity

source: SEC Form 4

open-market buys + sells

Apr 7, 26SELLCowan Elvia· SVP, Finance & CAO3,000 sh @ $60.00−$180K↗
Apr 1, 26SELLWassil Jim· CHIEF OPERATING OFFICER1,412 sh @ $58.14−$82K↗
Apr 1, 26SELLWassil Jim· CHIEF OPERATING OFFICER838 sh @ $58.93−$49K↗
Mar 17, 26SELLCowan Elvia· SVP, Finance & CAO1,487 sh @ $55.39−$82K↗
Mar 17, 26SELLCowan Elvia· SVP, Finance & CAO405 sh @ $56.26−$23K↗
Mar 11, 26SELLCowan Elvia· SVP, Finance & CAO2,500 sh @ $58.59−$146K↗
Mar 10, 26SELLWassil Jim· CHIEF OPERATING OFFICER4,968 sh @ $59.16−$294K↗
Mar 10, 26SELLWassil Jim· CHIEF OPERATING OFFICER2,427 sh @ $58.32−$142K↗

routine RSU / option mechanics (6)

Apr 7, 26option exerciseCowan Elvia · SVP, Finance & CAO3,000 sh
Apr 7, 26option exerciseCowan Elvia · SVP, Finance & CAO3,000 sh
Mar 11, 26option exerciseCowan Elvia · SVP, Finance & CAO2,500 sh
Mar 11, 26option exerciseCowan Elvia · SVP, Finance & CAO2,500 sh
Mar 9, 26tax coverPICKERING GRANT · CHIEF EXECUTIVE OFFICER3,685 sh

$PCVX58.39+4.12%

Mar 9, 26

tax cover

GUGGENHIME ANDREW · PRESIDENT AND CFO

1,021 sh